论文部分内容阅读
肺炎支原体(MP)属于柔膜体纲支原体科支原体属,为无细胞壁并能在无生命培养基上生长的最小原核型微生物,是呼吸系统疾病常见病原体之一,秋冬季节发病较多。目前已成为社区获得性肺炎(CAP)的第3位病原体[1-2]。肺炎支原体感染者,起病2周后,约2/3的患者冷凝集试验阳性[3]。出现冷凝集效价较高的肺炎患者,应及时结合肺炎支原体血清抗体检测,肺炎支原体PCR检查,从而明确病原体诊断及
Mycoplasma pneumoniae (MP) belongs to the genus Mycoplasma Mycoplasma Mycoplasma genus, is a cell-free wall and can grow in the non-living medium, the smallest prokaryotic microorganisms, is a common respiratory disease pathogens, more incidence in autumn and winter. It has now become the third causative agent of community acquired pneumonia (CAP) [1-2]. Mycoplasma pneumoniae infection, 2 weeks after onset, about 2/3 of patients with cold agglutination test was positive [3]. Patients with pneumoconiosis with high titer of agglutination set should be timely combined with the serum antibody test of Mycoplasma pneumoniae and PCR test of Mycoplasma pneumoniae so as to confirm the diagnosis of pathogens and